ENTITY Weitai Bio

Weitai Bio

PulseAugur coverage of Weitai Bio — every cluster mentioning Weitai Bio across labs, papers, and developer communities, ranked by signal.

Total · 30d

1

1 over 90d

Releases · 30d

0

0 over 90d

Papers · 30d

1

1 over 90d

TIER MIX · 90D

RECENT · PAGE 1/1 · 1 TOTAL

SIGNIFICANT · CL_09633 · Apr 30 · 00:00

Weitao Bio raises over $50M for in-vivo CAR-T therapy platform

Weitai Bio, a company spun out from Shalier Bio, has secured over $50 million in Series A and A+ funding. The company is advancing its lead drug candidate, GT801, which utilizes a lipid nanoparticle (LNP) delivery syste…